Abstract:ObjectiveTo evaluate the antitumor capability and to investigate the underlying molecular mechanism of paclitaxel.MethodsFirst, cck‐8 and apoptosis assays were used to determine survival and apoptotic effects of HS 737.T cells under treatment of paclitaxel. Next, RNA‐seq and bioinformatics were used to determine the differentially expressed genes and to analyze the pathway involved. Quantitative real‐time polymerase chain reaction was used to verify the accuracy of some differentially expressed genes (DEG). ClueGO was used to decode and visualize functionally grouped GO terms of differentially expressed genes, and to map the DEG protein–protein interactions (PPI) network. Western blotting was used to check the expression of target genes, the cleavage of Caspase‐3 and PARP1, and the phosphorylation level of p53. Finally, transcriptomics, bioinformatics, and RNAi were used to estimate the antitumor capability and to identify the underlying mechanisms of paclitaxel in GCTB.ResultsOur data revealed that paclitaxel had significant time‐dependent effects on the viability and induced apoptosis of HS 737.T cells. RNA‐seq and bioinformatics analysis showed that apoptosis, death receptor signaling pathway, TNF signaling pathway, and TP53 regulated transcription of cell death genes pathway were closely associated with paclitaxel in the treatment of GCTB. Western bolt results revealed that paclitaxel induced cleavage of Caspase‐3 and PARP1, and increased the phosphorylation level of p53 in HS 737.T cells. RNAi results showed that the expression level of TP53INP1 was significantly decreased in HS737.T cells (the decrease was more than 70%). In addition, we found that the inhibitory ratios of paclitaxel on HS737.T cells deficient in TP53INP1 were less than in HS737.T cells with empty vector (19.88 and 40.60%, respectively). Hence, our data revealed that TP53INP1 regulated paclitaxel‐driven apoptosis in HS737.T cells.ConclusionPaclitaxel can significantly repress cell proliferation and induce apoptosis of HS 737.T cells through activating Caspase‐3, PARP1, p53, and TP53INP1. Paclitaxel may be an effective drug in the management of GCTB.

Paclitaxel Induces Apoptosis Via Caspase-3 Activation in Human Osteogenic Sarcoma Cells (U-2 Os)

Paclitaxel-induced Apoptosis in Osteosarcoma Cell Line U-2 OS.

Induction of Apoptosis by a Combination of Paclitaxel and Carboplatin in the Presence of Hyperthermia.

Enhancement of Osteosarcoma Cell Sensitivity to Cisplatin Using Paclitaxel in the Presence of Hyperthermia

Effect of Paclitaxel on Apoptosis and bcl-2,bax Gene Expression in Human Osteosarcoma Cell

Paclitaxel Induces Apoptosis in Osteosarcoma Via Promoting the Production of Reactive Oxygen Species and Inhibiting the Expression of Cyclooxygenase-2

Paeoniflorin induces G2/M cell cycle arrest and caspase-dependent apoptosis through the upregulation of Bcl-2 X-associated protein and downregulation of B-cell lymphoma 2 in human osteosarcoma cells.

Induction of caspase-3-dependent apoptosis in human leukemia HL-60 cells by paclitaxel.

Tetrandrine induces apoptosis and triggers a caspase cascade in U2-OS and MG-63 cells through the intrinsic and extrinsic pathways.

Inhibitory Effects of PARP-1 Inhibitor on Growth of Human Osteosarcoma Cells.

Establishment of a new paclitaxel resistant cell line of human ovarian carcinoma and preliminary observation of its biology.

Proteasome Inhibitor MG132 Enhances TRAIL-induced Apoptosis and Inhibits Invasion of Human Osteosarcoma OS732 Cells

Cantharidin Inhibits Anti-Apoptotic Bcl-2 Family Proteins and Induces Apoptosis in Human Osteosarcoma Cell Lines MG-63 and MNNG/HOS Via Mitochondria-Dependent Pathway.

Overexpression of Glycogen Synthase Kinase-3 in Ovarian Carcinoma Cells with Acquired Paclitaxel Resistance

Paclitaxel Induces Apoptosis of Esophageal Squamous Cell Carcinoma Cells by Downregulating STAT3 Phosphorylation at Ser727.

Paclitaxel Induces Apoptosis in Human Gastric Carcinoma Cells

Paclitaxel Induce Apoptosis of Giant Cells Tumor of Bone Via TP53INP1 Signaling

The Possible Correlation Between Activation of NF-kappaB/IkappaB Pathway and the Susceptibility of Tumor Cells to Paclitaxel-Induced Apoptosis.

Experimental studies on paclitaxel - induced apoptosis and growth inhibitory effects in Ewing sarcoma cell line of RD-ES in Vitro

Ouabain Induces Apoptotic Cell Death Through Caspase- And Mitochondria-Dependent Pathways In Human Osteosarcoma U-2 Os Cells

IκB Kinase Activation is Involved in Regulation of Paclitaxel-Induced Apoptosis in Human Tumor Cell Lines